chilar4567
5 days ago
ELSE NUTRITION ANNOUNCES DELAY IN FILING FINANCIAL STATEMENTS AND EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
2:24 PM ET 6/19/25 | Dow Jones
VANCOUVER, BC, June 19, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that the Company's principal regulator in Canada, the British Columbia Securities Commission (the "BCSC"), has notified the Company that it has issued a cease trade order (the "CTO") under Multilateral Instrument 11-103 Failure-to-File Cease Trade Orders in Multiple Jurisdictions against the Company. The CTO was issued as a result of the Company's delay in filing its interim financial statements, the accompanying management discussion and analysis, and CEO and CFO certifications for the period ended March 31, 2025 (the "Interim Filings") on SEDAR+ within 45 days after the end of its interim period on March 31, 2025.
The CTO prohibits the trading by any person or company of any securities of the Company in each jurisdiction in Canada in which the Company is a reporting issuer, until such time as the Company is able to complete the filing of the Interim Filings and successfully apply for a revocation of the CTO. The CTO provides an exception for beneficial securityholders of the Company who are not currently (and were not as of June 16, 2025) insiders or control persons of the Company and who sell securities of the Company acquired before June 16, 2025, if both of the following criteria are met: (i) the sale is made through a "foreign organized regulated market", as defined in section 1.1 of the Universal Market Integrity Rules of the Investment Industry Regulatory Organization of Canada, and (ii) the sale is made through an investment dealer registered in a jurisdiction of Canada in accordance with applicable securities legislation.
The Company expects to file its Interim Filings by June 30, 2025 and will issue a news release once they have been filed.
Extension of Annual General Meeting of Shareholders
In addition, the Company announces that the Toronto Stock Exchange has granted the Company an extension to hold its annual general meeting of shareholders for 2025 (the "AGM"), which it was originally required to be held by June 30, 2025. The Company is now required to hold the AGM by July 31, 2025.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit
-- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler
Formula Category
-- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
-- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category
-- During September 2022, Else Super Cereal reached the #1 Best Seller in
Baby Cereal across all brands on Amazon
For more information, visit www.elsenutrition.com or @elsenutrition on Facebook and Instagram.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include but are not limited to, statements with respect to the Company filing its interim financial statements and MD&A. These forward-looking statements are made as of the date of this press release. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Although the Company believes the forward-looking statements in this press release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors and assumptions include, among others, variations in market conditions; currency exchange rates; the Company's ability to obtain any necessary permits, consents or authorizations required for its activities; the Company's ability to access further funding, to continue its projected growth, or to be fully able to implement its business strategies. In addition, there are known and unknown risk factors which could cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-announces-delay-in-filing-financial-statements-and-extension-of-annual-general-meeting-of-shareholders-302486531.html
SOURCE Else Nutrition Holdings Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2025/19/c2074.html
/CONTACT:
For more information, contact: Mrs. Hamutal Yitzhak, CEO, Co-Founder & Director, ELSE Nutrition Holdings Inc., E: hamutaly @; Investor Relations Contact: Alexandra Schilt, Crescendo Communications, LLC, Office: (212) 671-1020, Email: baby@crescendo-ir.com
Copyright CNW Group 2025
> Dow Jones Newswires
June 19, 2025 14:24 ET (18:24 GMT)
gfp927z
6 days ago
Bar, >> organic baby food <<
This still looks like an interesting niche area, so maybe these guys will have better luck (article below). Looks like heavyweights Goldman and JPM will be underwriting the IPO, so a good sign.
Else's over-reliance on buckwheat may have been a key mistake. While buckwheat is nutritious, the taste isn't great, and it's also high in lectins, which can irritate the GI tract. In contrast, Once Upon a Farm uses --> avocado, blueberry, coconut milk, flaxseed, ginger, kale, mango, pumpkin seed, spinach, sweet potato, strawberry, turmeric. Taste is the key to getting kids to love the product, and Else apparently came up way short in the taste department -
>>> Jennifer Garner's baby food company confidentially files for an IPO, sources say
Reuters
June 18, 2025
by Echo Wang and Abigail Summerville
https://finance.yahoo.com/news/jennifer-garners-baby-food-company-180711826.html
(Reuters) - Once Upon a Farm, the organic baby food company co-founded by actor Jennifer Garner, has filed confidentially for an initial public offering in New York, according to people familiar with the matter.
The Berkeley, California-based company has tapped a group of investment banks for the IPO, which could occur as soon as this year, said the sources, who cautioned that the plans could change, depending on market conditions. Goldman Sachs and JPMorgan are the lead underwriters, said the sources, who requested anonymity because the plans are confidential.
The offering could value the company at about $1 billion, one of the persons said. Once Upon a Farm did not immediately respond to a request for comment, Goldman Sachs and JPMorgan declined to comment.
Garner is known for her work in the TV drama "Alias" and films including "Dallas Buyers Club" and "Catch Me If You Can." A mother of three, she has said she cares deeply about childhood nutrition, and she grows some produce for Once Upon a Farm on her family's century-old farm in Oklahoma.
Once Upon a Farm was founded in 2015 by Cassandra Curtis and Ari Raz to create more nutritious baby-food options. In 2017, Garner and John Foraker, the former CEO of food brand Annie's, joined the company as co-founders.
The company's products for babies, toddlers and children range from oat bars to cold-pressed pouches and frozen meals, and they are sold in supermarkets across the U.S.
An IPO for the company would build on momentum for market debuts in the U.S., a sector that has lately thawed after the Trump administration's tariff announcements earlier this year cast a chill. So far this year, IPOs listed in the U.S. have raised about $27 billion, down from $41 billion in the same period last year, according to data compiled by Dealogic. But this year's figure is more than in 2022 and 2023, when IPOs raised $22 billion and $24 billion, respectively, over the same time frame, according to Dealogic.
In its Nasdaq debut last week, digital bank Chime jumped 59%, valuing the company at $18.4 billion. The stock of stablecoin issuer Circle Internet Group climbed to $103.75 and was halted several times for volatility during a wild first day of trading earlier this month.
<<<
---
chilar4567
2 weeks ago
Else Nutrition Applauds U.S. Government's Historic Shift in Infant Formula Rules, Unlocking Path to Commercialize the World's First Whole-Food, Dairy-Free Infant Formula
7:30 AM ET 6/10/25 | Dow Jones
Else Nutrition Welcomes 3 Major Federal Developments that Could Unlock Market Access & Open the Door to the First Major Breakthrough in Infant Formula in Decades
VANCOUVER, BC, June 10, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), a global leader in clean label, plant-based childhood nutrition, welcomes a recent trio of significant policy signals from the U.S. Government that could reshape the nation's infant formula landscape.
These developments - spanning FDA regulatory reform, Congressional oversight, and executive action - reflect growing national momentum to modernize outdated regulations and expand consumer choice in baby formula.
National Academy Report Supports Smarter Science, Aligns with Else's Regulatory Approach
In a move that could have broad implications for new formula entrants, the FDA commissioned a National Academy of Sciences study to examine global regulatory standards for infant formula - particularly focusing on the outdated Protein Efficiency Ratio (PER) study, which had long served as a barrier for plant-based options like Else's.
The newly released study recommends replacing the outdated PER test with modern, evidence-based alternatives that better reflect international norms and nutritional science. This marks a turning point for Else, whose regulatory strategy has been built around these same more progressive standards.
"We are encouraged by the Academy's findings and look forward to these recommendations informing forthcoming FDA guidance," said Hamutal Yitzhak, CEO & Co-Founder, Else Nutrition.
Congressional Pressure Grows for Modernized Plant-Based Infant Formula Pathway
In parallel, Else Nutrition welcomes mounting attention to infant formula policy from the United States Congress. Earlier this year, top Republican Appropriators - a Members of a powerful Committee in Congress that maintains the "Power of the Purse" - sent a formal Congressional Oversight letter to the agency, urging the FDA to create a clear, modernized regulatory pathway for plant-based infant formula that matches the international standard. Congress' intent reflects a shared perspective that the National Academy study unveiled.
This rare Congressional intervention emphasizes the urgency of reform and calls for U.S. policy to upgrade to international standards that already embrace plant-based options. It also signals the potential for future Congressional action to reinforce the need for change and hold the FDA accountable.
"Congressional Appropriators are sending a strong signal that American parents deserve safe, vetted plant-based alternatives, and that companies like Else deserve a fair, science-aligned path to market, with regulatory guidance to match," added Ms. Yitzhak.
Administration Launches 'Operation Stork Speed' to Cut Red Tape
Furthering the support is the Administration's new initiative, Operation Stork Speed, aimed at accelerating access to infant formula by streamlining regulatory processes and clearing bureaucratic roadblocks. The program is expected to fast-track FDA reforms while ensuring safety and nutritional integrity.
Else Nutrition looks forward to engaging directly with the Administration to help shape a smarter, more inclusive infant formula future.
A New Era of Opportunity for Infant Nutrition
Together, these three developments - scientific, legislative, and executive - signal a generational shift in how the U.S. regulates and supports infant nutrition. For Else Nutrition, they offer renewed confidence that the path forward is finally being cleared. This initiative is a direct complement to the Congressional attention and the National Academy study, and Else looks forward to collaborating with the Administration.
"These reforms aren't just good for Else - they're good for every parent seeking cleaner, safer, baby formula options beyond dairy," said Ms. Yitzhak. "We continually get requests from so many families in real need of finding an alternative beyond dairy-based baby formula. We're proud to be at the forefront of this movement for change and are ready to serve American families with the trusted nutrition they deserve."
chilar4567
3 weeks ago
Press Release: Else Nutrition Reports 2024 Fiscal Year Financial Results and Provides Business Update
1:12 PM ET 6/2/25 | Dow Jones
Conference call to be held Tuesday, June 3(rd) at 10:00 AM Eastern Time
VANCOUVER, BC, June 2, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), reported financial results for the 2024 fiscal year ended December 31, 2024. The financial statements and MD&A are available on SEDAR under the Company's profile.
"2024 was a defining year for Else Nutrition, marked by significant challenges that ultimately led to pivotal decisions shaping our future," commented Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "While we encountered major headwinds, including funding constraints, inventory shortages, and a limited marketing budget, we took decisive actions to secure our future. Specifically, we optimized operations, significantly reduced overhead costs, and secured essential funding. We also streamlined our cost structure by cutting underperforming roles, reducing low-ROI marketing spend, and exiting unprofitable retail partnerships. In addition, we restructured R&D operations, including the closure of our Israel lab, to preserve innovation capacity while improving financial performance. Furthermore, we plan to expand our manufacturing and prepare our powder formula in Europe, which will lower production costs, improve margins, and enhance product quality."
"Despite our challenges, we made important progress including successfully launching our first Adult Ready-to-Drink (RTD) product, expanding retail placement for our Kids RTD product, and increasing our presence in the U.S. through e-commerce platforms. These milestones reflect the growing demand for plant-based, allergen-friendly nutrition, and we intend to capitalize on these opportunities."
"On the regulatory front, we are encouraged by the FDA and HHS's launch of Operation Stork Speed, an initiative aimed at expanding infant formula options and strengthening supply chain resilience. Through our continued bipartisan advocacy efforts, we aim to make significant progress toward modernizing FDA guidelines for plant-based, non-soy, non-dairy infant formula. We look forward to working closely with regulators to establish a clear pathway, ensuring that parents have access to safe, high-quality, and scientifically backed nutrition alternatives."
"Furthermore, we were recently featured in an op-ed published in The Washington Times, titled "Operation Stork Speed will ensure babies get the nutrition they need." The piece highlights the importance of accelerating access to clean-label, plant-based alternatives and aligns with our broader mission and ongoing advocacy efforts in Washington to promote science-backed updates to infant nutrition guidelines."
"Looking ahead to 2025, we are focused on expanding our retail distribution, scaling our European production, and enhancing brand visibility through targeted marketing and strategic partnerships. With a solid foundation in place, Else Nutrition is well-positioned for long-term growth, and we remain committed to delivering clean-label, plant-based nutrition solutions that meet the needs of families worldwide."
2024 Fiscal Year Financial Results
All figures are in CAD unless otherwise indicated.
-- Revenue for 2024 decreased approximately 14.8% to $8 million compared to
$9.4 million for 2023.
-- Operating expenses for 2024 was $13.6 million, a decrease of 20% compared
to $16.9 million for 2023
-- Cash balance as of December 31, 2024, was $0.3 million (including
restricted cash).
Conference Call
Else Nutrition management plans to host a business update conference call Tuesday, June 3(rd) at 10:00 a.m. Eastern Time to discuss the Company's financial results for the 2024 fiscal year ended December 31, 2024, as well as the Company's corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 1-877-407-9219 for U.S. callers or +1-412-652-1274 for international callers. A webcast of the call may be accessed at https://event.choruscall.com/mediaframe/webcast.html?webcastid=vDEyPa8B or on the Investor Relations section of the Company's website at https://investors.elsenutrition.com/.
A webcast replay will be available on the Investor Relations section of the Company's website (https://investors.elsenutrition.com/), through June 3, 2026. A telephone replay of the call will be available approximately three hours following the call, through June 17, 2025, and can be accessed by dialing 1-877-660-6853 for U.S. callers or +1-201-612-7415 for international callers and entering conference ID: 13754118.
To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit
-- #1 Best Seller on Amazon in the Fall of 2020 in the New Bab
chilar4567
4 weeks ago
(PR) Else Nutrition CEO Highlights Urgent Need for Infant Formula Alternatives in The Washington Times Op-Ed
7:30 AM ET 5/28/25 | PR Newswire
VANCOUVER, BC, May 28, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) ("Else" or the "Company"), a pioneer in wholefood, Plant-Based nutrition for babies, toddlers, children and adults, is pleased to announce that its CEO and Co-Founder, Hamutal Yitzhak, authored a featured op-ed published in The Washington Times on May 25, 2025. Titled "Operation Stork Speed will ensure babies get the nutrition they need," the piece highlights the urgent need to modernize the infant formula regulatory environment and emphasizes the importance of increasing access to safe and innovative nutrition options--particularly for infants with dietary restrictions or allergen sensitivities. The Washington Times has a substantial readership in Washington, D.C., particularly among Congress and the Administration.
"Our mission has always been to deliver a safe, plant-based infant formula that supports healthy development and gives families--especially those with dietary or dairy/soy allergen concerns--greater access to trusted nutrition," said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. "Operation Stork Speed is an excellent initiative designed to expand access to these types of formulas, and as noted in the Washington Times op-ed, we look forward to continuing to collaborate with the White House, policymakers, and the FDA as we look to bring our unique solution to market in a swift and responsible manner."
Regulatory Pathway and Status
Else Nutrition has developed a clean-label, whole plant-based infant formula intended as an alternative to dairy- and soy-based products. In 2023, the Company successfully concluded the pre-clinical studies required and received Institutional Review Board (IRB) approval for its infant growth clinical study protocol--marking a key step toward U.S. Food and Drug Administration (FDA) compliance. At present, the Company is awaiting final authorization from the FDA to initiate its clinical trial in the United States, pending regulatory modernization that the company believes may be accelerated through Operation Stork Speed. Several Congressional Appropriators recently called on the FDA to accelerate this effort, as directed through an oversight letter.
Policy Advocacy and Operation Stork Speed
The op-ed coincides with the recent launch of Operation Stork Speed, an initiative by the Trump administration and Health and Human Services Secretary Robert F. Kennedy Jr., aimed at improving the regulatory review and safety of infant formula in the United States as well as encouraging innovation and transparency in formula composition to serve unmet needs. Ms. Yitzhak's commentary lends industry perspective to this national conversation and urges regulatory authorities to accelerate the path to market for scientifically supported, non-traditional formula options.
Else Nutrition is actively engaged in this effort through direct outreach to policymakers, bipartisan advocacy on Capitol Hill, and consumer education. The Company continues to advocate for updated infant formula guidelines that recognize the validity and safety of plant-based, non-soy, allergen-friendly alternatives.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food an
chilar4567
4 weeks ago
Else Nutrition Expands Nationwide with Kids Ready-to-Drink Shakes in 1,000 Leading U.S. Retailer Stores
7:30 AM ET 5/27/25 | Dow Jones
VANCOUVER, BC, May 27, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), a leader in plant-based nutrition for early life and adult nutrition, is excited to announce its expanded footprint in the U.S. retail market with the launch of its Ready-to-Drink (RTD) products in a leading grocery retail chain. Starting May 2025, Else's clean-label Kids RTD products are available in 1,000 stores nationwide.
Launched in 2024, Else's ready-to-drink kids' shakes quickly gained traction among parents seeking nutritious, dairy-free, and soy-free options for their children.
"We are thrilled to see our RTD line gain a prominent spot on the shelves of this retail giant," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "This milestone demonstrates the strength of the Kids RTD category and the increasing consumer demand for clean-label, plant-based options. Kids don't need another ultra-processed drink, and our minimally processed ingredients-based shakes are the only whole-food-based option that both parents and kids love."
To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com
chilar4567
2 months ago
(PR) Else Nutrition Launches 'Formula for Change' Campaign, Building on Momentum from Operation Stork Speed to Deliver Real Choice for American Families
7:00 AM ET 4/23/25 | PR Newswire
Else Nutrition Launches 'Formula for Change' Campaign, Building on Momentum from Operation Stork Speed to Deliver Real Choice for American Families
PR Newswire
VANCOUVER, BC, April 23, 2025
A Bold Step Toward Inclusion: Else Nutrition Aims to Deliver a Real Alternative for Millions of Babies Who Can't Tolerate Dairy-Based Formula
VANCOUVER, BC, April 23, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), a global leader in clean-label, plant-based childhood nutrition, is launching a bold new advocacy campaign--'Formula for Change'--to accelerate U.S. regulatory support for clinical trials of its breakthrough dairy-free, soy-free infant formula.
This initiative builds on the positive momentum of Operation Stork Speed, a recent federal effort to fast-track next-generation infant formula development. Else Nutrition applauds this long-overdue modernization effort and urges the FDA to take the next step by opening innovative regulatory pathways for clinical trials of Else's infant formula. This will help ensure American families finally gain access to a safe, inclusive, and science-backed alternative to traditional dairy-based formulas.
"We're inspired by Operation Stork Speed," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "It signals a shift toward innovation and inclusivity in infant nutrition. Now we're calling on the FDA and U.S. representatives to act on this progress and greenlight clinical trials that will allow us to bring our transformational option to families who've waited too long."
The First Real Innovation in a Generation
For decades, U.S. parents have had just two options: dairy or soy. But countless babies are unable to tolerate either. Families making plant-based lifestyle choices have similarly been left without viable options. Else Nutrition has developed the world's first infant formula based on whole plant ingredients, including almonds and buckwheat--free from dairy, soy, and ultra-processed ingredients. Already gaining international traction, the formula mirrors the nutritional benefits and profile of human milk and holds the Clean Label Project Purity Award for exceptional safety.
Pushing Forward with Progress - Not Hitting a Wall
While the product is already available abroad, outdated U.S. regulations currently prevent Else from initiating clinical trials required for infant formula approval. The Company sees Operation Stork Speed as a meaningful foundation to modernize these outdated systems and believes the time is ripe for inclusion of Plant-Based innovation in these efforts.
"We've already heard from thousands of U.S. families about how our toddler formula changed their children's lives," said Yitzhak. "Operation Stork Speed gives us hope--but hope needs action. Modernizing regulatory pathways is the crucial next step to enable innovation for the babies who need it most."
Why Else Nutrition Supports Operation Stork Speed
Else Nutrition is actively seeking inclusion in Operation Stork Speed to help close a dangerous gap in infant nutrition:
-- U.S. regulations lag behind Europe, Canada, and Australia.
-- Many U.S. formulas contain toxic metals or synthetic additives.
-- Four companies control the market, creating vulnerability and limiting
innovation.
-- The 2022--2023 formula shortage crisis exposed deep systemic weaknesses.
Operation Stork Speed seeks to address these issues by encouraging innovation--and Else's formula represents exactly the kind of science-driven, next-generation product this program is designed to support.
Join the Movement: Demand Real Choice
Else Nutrition is mobilizing parents, pediatric professionals, and policymakers to advocate for inclusive, evidence-based nutrition. With public support and FDA cooperation, the Company can launch clinical trials and bring its formula to American shelves.
Here's how you can help drive the Formula for Change:
1. Email your Member of Congress to urge FDA action on modern regulatory
pathways.
2. Sign the petition on Change.org to amplify the public voice.
3. Pledge your support--$25, $50, or $100--to help Else advance clinical
readiness.
Learn more and take action today: https://elsenutrition.com/pages/realchoice
DISCLAIMERS
This grassroots lobbying effort is a statement of issue advocacy and does not require disclosure under the Lobbying Disclosure Act. This is not an electioneering statement, and this message has not been coordinated with any political parties or candidates. This message is paid for by Else Nutrition and is intended for only a "restricted class" of stockholders and administrators of the company. Whereas this is an instance of grassroots lobbying, Else Nutrition's engaged lobbying principals file disclosures required under the Lobbying Disclosure Act for direct lobbying services on behalf of the company.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards
chilar4567
3 months ago
(PR) ELSE NUTRITION GRANTED VOLUNTARY MANAGEMENT CEASE TRADE ORDER
8:49 PM ET 4/1/25 | PR Newswire
ELSE NUTRITION GRANTED VOLUNTARY MANAGEMENT CEASE TRADE ORDER
PR Newswire
VANCOUVER, BC, April 1, 2025
VANCOUVER, BC, April 1, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that it has been granted a voluntary management cease trade order in accordance with National Policy 12-203 due to it not being able to file its annual financial statements, management's discussion and analysis ("MD&A") and annual information form ("AIF") for the year ended December 31, 2024 on SEDAR within 90 days of its financial year-end. The management cease trade order has been granted by the Company's principal regulator, the British Columbia Securities Commission.
The Company concluded that it would not be in a position to complete the year-end audit within the time periods required by National Instrument 51-102 due to timing constraints in completing audit procedures. As a result, the Company requires additional time to file its annual financial statements, MD&A and AIF for the financial year ended December 31, 2024.
The Company expects to file its annual financial statements, MD&A and AIF for the year ended December 31, 2024 by April 9, 2025 and in any event no later than May 30, 2025, and will issue a news release once they have been filed. The Company intends to satisfy the provisions of the alternative information guidelines of National Policy 12-203, by issuing bi-weekly default status reports, in the form of news releases, until the revocation of the management cease trade order. The Company is not subject to any insolvency proceedings. The management cease trade order will prohibit the chief executive officer and the chief financial officer of the Company from trading in securities of the Company for so long as the annual financial statements, MD&A and AIF are not filed. The issuance of the management cease trade order does not affect the ability of persons other than the chief executive officer and the chief financial officer of the Company to trade in the Company's securities.
About Else Nutrition Holdings Inc.
chilar4567
3 months ago
Else Nutrition Schedules 2024 Fiscal Year Business Update Conference Call
7:00 AM ET 3/21/25 | Dow Jones
Else Nutrition Schedules 2024 Fiscal Year Business Update Conference Call
Canada NewsWire
VANCOUVER, BC, March 21, 2025
VANCOUVER, BC, March 21, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), today announced that it plans to host a business update conference call at 10:00 a.m. Eastern Time on March 31, 2025 to discuss the Company's financial results for the 2024 fiscal year ended December 31, 2024, as well as the Company's corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 1-877-407-9219 for U.S. callers or +1-201-689-8852 for international callers. A webcast of the call may be accessed at https://event.choruscall.com/mediaframe/webcast.html?webcastid=xEF3gH7K or on the Investor Relations section of the Company's website at https://investors.elsenutrition.com/.
A webcast replay will be available on the Investor Relations section of the Company's website (https://investors.elsenutrition.com/), through March 31, 2026. A telephone replay of the call will be available approximately three hours following the call, through April 14, 2025, and can be accessed by dialing 1-877-660-6853 for U.S. callers or +1-201-612-7415 for international callers and entering conference ID: 13752367.
Interested parties who would like to submit a question to be addressed on the call can email the question to baby@crescendo-ir.com.
To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is
chilar4567
3 months ago
Else Nutrition Commends HHS & FDA's Operation Stork Speed on Expanding Infant Formula Options
PR Newswire
VANCOUVER, BC, March 20, 2025
HHS/FDA Announcement Bolsters Else Nutrition's Momentum in Bringing its Infant Formula to Market in the United States
VANCOUVER, BC, March 20, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), applauds the leadership of Secretary Robert F. Kennedy in launching Operation Stork Speed, a strategic initiative by the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) aimed at expanding infant formula options. This effort demonstrates the importance of nutritional adequacy and supply chain resilience while facilitating the development of new infant formulas within the United States.
As part of its commitment to bringing the first whole food, minimally processed, clean-label, plant-based infant formula to American families, Else Nutrition has been actively engaged in a robust Washington D.C. effort through its U.S. office. This includes hiring a leading healthcare lobbying firm, conducting bipartisan Congressional meetings across both chambers, and preparing to launch a grassroots lobbying program. To date, this effort has resulted in significant Congressional oversight on modernized FDA guidance on plant-based, non-soy, non-dairy infant formula options--an essential step for Else Nutrition to conduct key clinical trials in the U.S.
In January 2025, the FDA released their Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market, which followed the National Academies of Sciences, Engineering, and Medicine also recently convening a study on these issues. This week's announcement of Operation Stork Speed is another significant step from HHS in ensuring access to safe, high quality infant formulas.
"At Else Nutrition, we are dedicated to ensuring that families across America have access to safe, high-quality, minimally processed plant-based nutrition options," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "Many infants with medical, dietary or dietary needs require such formulas. Congress has taken significant action to ensure access to these formulas and we are pleased to see the Administration continue this most important work. We applaud President Trump and Secretary Robert F. Kennedy for their leadership in launching Operation Stork Speed and look forward to collaborating with HHS and the FDA to create a modernized regulatory pathway for plant-based, non-soy, non-dairy infant formulas. By combining rigorous science with the power of natural ingredients like almonds, buckwheat, and tapioca, we are redefining early childhood nutrition to be healthier, more sustainable, and more accessible to parents seeking clean-label alternatives."
About Else Nutrition Holdings Inc.
bar1080
5 months ago
No wonder it keeps dropping.
"Else Nutrition expects to use the proceeds for general working capital." in other words, pay raises perhaps.
Else Nutrition Amends Convertible Security Financing
7:35 AM ET 1/24/25 | MT Newswires
Else Nutrition Amends Convertible Security Financing
07:35 AM EST, 01/24/2025 (MT Newswires) -- Else Nutrition (BABY.TO), trading near its 52-week low, overnight Thursday said it signed a non-binding term sheet with Lind Global Fund II, pursuant to which both parties expect to amended a convertible security funding agreement for US$1.2 million in proceeds.
The company and Lind expect the proposed new funding to be completed in four tranches with the initial US$300,000 to be funded by Lind upon closing, followed by three additional tranches on April 1, July 1, and Oct. 1. Else Nutrition will issue convertible securities to Lind with a face value of US$375,000 for each tranche, with each convertible security having a 24-month maturity date.
Each convertible security is convertible into common shares after the 120-day lock-up period. The company will also issue detached warrants to Lind to buy shares related to the new funding and will be exercisable for 48 months from the date of issuance with an exercise price equal to 100% of the 5-day VWAP immediately prior to the closing date.
Else Nutrition expects to use the proceeds for general working capital.
Shares of the company closed up $0.0050 or 16%, to $0.0350 on Thursday on the Toronto Stock Exchange.
Please read all the important disclosures below.
Investing:
Check the background of Morgan Stanley Smith Barney LLC on FINRA's BrokerCheck and see the Morgan Stanley Smith Barney LLC Relationship Summary.
chilar4567
5 months ago
Else Nutrition Amends Convertible Security Financing
7:35 AM ET 1/24/25 | MT Newswires
Else Nutrition Amends Convertible Security Financing
07:35 AM EST, 01/24/2025 (MT Newswires) -- Else Nutrition (BABY.TO), trading near its 52-week low, overnight Thursday said it signed a non-binding term sheet with Lind Global Fund II, pursuant to which both parties expect to amended a convertible security funding agreement for US$1.2 million in proceeds.
The company and Lind expect the proposed new funding to be completed in four tranches with the initial US$300,000 to be funded by Lind upon closing, followed by three additional tranches on April 1, July 1, and Oct. 1. Else Nutrition will issue convertible securities to Lind with a face value of US$375,000 for each tranche, with each convertible security having a 24-month maturity date.
Each convertible security is convertible into common shares after the 120-day lock-up period. The company will also issue detached warrants to Lind to buy shares related to the new funding and will be exercisable for 48 months from the date of issuance with an exercise price equal to 100% of the 5-day VWAP immediately prior to the closing date.
Else Nutrition expects to use the proceeds for general working capital.
Shares of the company closed up $0.0050 or 16%, to $0.0350 on Thursday on the Toronto Stock Exchange.
Please read all the important disclosures below.
Investing:
Check the background of Morgan Stanley Smith Barney LLC on FINRA's BrokerCheck and see the Morgan Stanley Smith Barney LLC Relationship Summary.
chilar4567
5 months ago
Else Nutrition Expands into Adult Nutrition Market with Launch of its Innovative Plant-based Ready-to-Drink Shakes
7:00 AM ET 1/21/25 | Dow Jones
Else Nutrition Expands into Adult Nutrition Market with Launch of its Innovative Plant-based Ready-to-Drink Shakes
Canada NewsWire
VANCOUVER, BC, Jan. 21, 2025
The U.S. dairy alternatives market is forecasted to grow from $5.84 billion in 2022 to $14.28 billion by 2030, reflecting a significant consumer shift toward plant-based products
VANCOUVER, BC, Jan. 21, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), a leader in clean, Plant-Based nutrition, announces its entry into the adult food market with the launch of its revolutionary ready-to-drink (RTD) nutritional shakes for adults in the U.S. and Canada.
As the first and only whole-food, plant-powered, complete nutrition drink for adults, Else Nutrition's RTD shakes are poised to redefine the adult nutritional beverage market. Notably, the U.S. dairy alternatives market is forecasted to grow from $5.84 billion in 2022 to $14.28 billion by 2030, reflecting a significant consumer shift toward plant-based products. Furthermore, 44% of flexitarians cite health benefits as a key driver in choosing plant-based options. Else Nutrition's RTD shakes meet this growing demand, offering a superior product that aligns with vegan, vegetarian, and flexitarian dietary preferences.
As more consumers embrace plant-based diets and seek sustainable, clean-label products, Else Nutrition's Adult RTD shakes offer a timely and innovative solution. Made from real, whole-food ingredients like almond butter, sunflower protein flour, and buckwheat flour, these dairy-free, minimally processed shakes provide a nutritious, easy-to-digest alternative to traditional dairy-based nutritional supplements.
A Complete Nutritional Solution
Each serving of Else Nutrition's RTD shake provides:
-- 280 calories and 14g of high-quality plant protein
-- Natural fiber, healthy carbohydrates, and unsaturated fats
-- 26 essential vitamins and minerals tailored to adults' health needs
-- 50% less sugar than leading competitors with no artificial sweeteners
-- Lactose-free, cholesterol-free, low in saturated fat, and Clean Label
Project Certified
Else Nutrition's RTD Vanilla shakes are now available in Canada in 8 fl. oz. (236 mL) tetra packs, offered in 6-packs and 24-packs. They can be purchased on Amazon.ca and at select retail locations. Additional flavors are planned for future release. In the U.S., the product line is set to launch in Q2 2025.
"We are proud to introduce a convenient, clean, and delicious option for adults looking to meet their daily nutritional needs," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "This launch is a natural progression of our mission to deliver whole-food-based nutrition for all ages. Our adult shakes aren't just better for you and easier to digest--they're better for the planet."
To delve deeper into Else Nutrition's offerings and its revolutionary approach to nutrition, visit www.elsenutrition.com
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and whole Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit
-- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler
Formula Category
-- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
-- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category
News
Market Data
Register to chat with like-minded investors on our interactive forums.
Ask ADVFN Intelligence (AI)
watchergrow
2 months ago
Musical Shares
2 months ago
